Education
About Us
Working with TipRanks
Follow Us
Medicamen Biotech Limited (IN:MEDICAMEQ)
:MEDICAMEQ
MEDICAMEQ Stock Chart & Stats
₹366.90
-₹10.20(-1.97%)
At close: 4:00 PM EST
₹366.90
-₹10.20(-1.97%)
Day’s Range― - ―
52-Week Range₹292.50 - ₹560.00
Previous CloseN/A
Volume10.37K
Average Volume (3M)2.40K
Market Cap
₹5.29B
Enterprise Value₹3.95B
Total Cash (Recent Filing)₹37.59M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)47.6
Beta1.62
Next Earnings
Feb 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.26%
Share Statistics
EPS (TTM)1.97
Shares Outstanding13,562,815
10 Day Avg. Volume3,620
30 Day Avg. Volume2,395
Financial Highlights & Ratios
PEG Ratio-2.50
Price to Book (P/B)2.95
Price to Sales (P/S)3.86
P/FCF Ratio-52.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MEDICAMEQ FAQ
What was Medicamen Biotech Limited’s price range in the past 12 months?
Medicamen Biotech Limited lowest stock price was ₹292.50 and its highest was ₹560.00 in the past 12 months.
What is Medicamen Biotech Limited’s market cap?
Medicamen Biotech Limited’s market cap is ₹5.29B.
When is Medicamen Biotech Limited’s upcoming earnings report date?
Medicamen Biotech Limited’s upcoming earnings report date is Feb 06, 2026 which is in 25 days.
How were Medicamen Biotech Limited’s earnings last quarter?
Medicamen Biotech Limited released its earnings results on Nov 14, 2025. The company reported ₹1.966 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.966.
Is Medicamen Biotech Limited overvalued?
According to Wall Street analysts Medicamen Biotech Limited’s price is currently Overvalued.
Does Medicamen Biotech Limited pay dividends?
Medicamen Biotech Limited pays a Notavailable dividend of ₹1 which represents an annual dividend yield of 0.26%. See more information on Medicamen Biotech Limited dividends here
What is Medicamen Biotech Limited’s EPS estimate?
Medicamen Biotech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medicamen Biotech Limited have?
Medicamen Biotech Limited has 13,562,815 shares outstanding.
What happened to Medicamen Biotech Limited’s price movement after its last earnings report?
Medicamen Biotech Limited reported an EPS of ₹1.966 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.412%.
Which hedge fund is a major shareholder of Medicamen Biotech Limited?
Currently, no hedge funds are holding shares in IN:MEDICAMEQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medicamen Biotech Limited
Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.
Technical Analysis
Ind-Swift Laboratories Ltd.
―
Nectar Lifesciences Ltd.
―
Sakar Healthcare Ltd
―
Venus Remedies Limited
―
Zim Laboratories Ltd.
―